haloperidol has been researched along with arginine vasopressin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (57.89) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hashimoto, K; Hosogi, H; Ofuji, N; Takahara, J; Yasuhara, T | 1 |
| Kendler, KS; Rubin, RT; Weitzman, RE | 1 |
| Delanoy, RL; Dunn, AJ; Tintner, R | 1 |
| Bridges, TE; Hillhouse, EW; Jones, MT | 1 |
| Lumeij, JT; Mol, JA; Rijnberk, A; van den Brom, WE; Westerhof, I | 1 |
| Forsling, ML; Wells, T | 1 |
| Hirai, M; Ikawa, G; Kishimoto, T; Matsuoka, I; Ohsawa, H; Terada, M | 1 |
| Angchanpen, P; Marin-Grez, M; Schnermann, J | 1 |
| Hama, H; Karakida, T; Koike, M; Yamaguchi, K | 1 |
| Imai, M; Kakki, N; Koyama, S; Sasaki, M; Setoyama, T; Suzuki, K; Takahashi, K; Togashi, K | 1 |
| Beckmann, H; Gattaz, WF; Lang, RE | 1 |
| Baertschi, AJ; Bény, JL | 1 |
| Brooks, DP; Claybaugh, JR | 1 |
| Mol, JA; Willemse, T | 1 |
| Hama, H; Watanabe, K; Yamaguchi, K | 1 |
| Feifel, D; Melendez, G; Priebe, K; Shilling, PD | 1 |
1 review(s) available for haloperidol and arginine vasopressin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
18 other study(ies) available for haloperidol and arginine vasopressin
| Article | Year |
|---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[In vitro assay for ACTH-releasing activity using ACTH radioimmunoassay: ACTH releasing activities by various drugs (author's transl)].
Topics: 5-Hydroxytryptophan; Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Dopamine; Dose-Response Relationship, Drug; Glucagon; Gonadotropin-Releasing Hormone; Haloperidol; Histamine; Hypothalamus; In Vitro Techniques; Indomethacin; Lypressin; Male; Norepinephrine; Phentolamine; Pituitary Gland, Anterior; Propranolol; Prostaglandins; Rabbits; Radioimmunoassay; Rats; Thyrotropin-Releasing Hormone; Tissue Extracts | 1976 |
Lack of arginine vasopressin response to central dopamine blockade in normal adults.
Topics: Adult; Arginine Vasopressin; Dopamine; Female; Haloperidol; Humans; Kinetics; Male; Prolactin; Reference Values | 1978 |
Behavioral responses to intracerebroventricularly administered neurohypophyseal peptides in mice.
Topics: Animals; Arginine Vasopressin; Behavior, Animal; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraventricular; Lypressin; Male; Mice; Oxytocin; Physostigmine; Reserpine; Syringes | 1978 |
The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro.
Topics: Acetylcholine; Animals; Apomorphine; Arginine Vasopressin; Biological Assay; Dopamine; Dopamine Antagonists; Female; Haloperidol; Hypothalamus; In Vitro Techniques; Male; Milk Ejection; Norepinephrine; Oxytocin; Phentolamine; Pituitary Gland, Posterior; Pituitary Hormones, Posterior; Pregnancy; Rats; Secretory Rate; Stimulation, Chemical | 1976 |
In vivo studies on the effects of ovine corticotrophin-releasing hormone, arginine vasotocin, arginine vasopressin, and haloperidol on adrenocortical function in the racing pigeon (Columba livia domestica).
Topics: Adrenal Cortex; Animals; Arginine Vasopressin; Columbidae; Corticosterone; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Female; Haloperidol; Male; Sheep; Vasotocin | 1992 |
Aminergic control of vasopressin secretion in the conscious rat.
Topics: Animals; Arginine Vasopressin; Consciousness; Dopamine; Dopamine Antagonists; Haloperidol; Hematocrit; Hypothalamus; Injections, Intraventricular; Male; Norepinephrine; Osmolar Concentration; Phenoxybenzamine; Propranolol; Rats; Rats, Sprague-Dawley; Sodium Chloride; Vasopressins | 1992 |
Manners of arginine vasopressin secretion in schizophrenic patients--with reference to the mechanism of water intoxication.
Topics: Adult; Animals; Arginine Vasopressin; Chlorpromazine; Female; Haloperidol; Humans; Hyponatremia; Male; Middle Aged; Rabbits; Schizophrenia; Water Intoxication; Water-Electrolyte Balance | 1989 |
Effect of dopamine antagonists on the urine flow of rats infused with hypotonic saline.
Topics: Animals; Antipsychotic Agents; Arginine Vasopressin; Benzazepines; Diuresis; Dopamine Antagonists; Haloperidol; Hypotonic Solutions; Male; Rats; Rats, Inbred Strains; Urodynamics | 1988 |
Central effects of catecholamine antagonists on angiotensin-induced vasopressin secretion in conscious rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Catecholamines; Dopamine; Haloperidol; Isoproterenol; Male; Phenoxybenzamine; Phenylephrine; Propranolol; Rats; Rats, Inbred Strains | 1988 |
Dopaminergic modulation of the renal effect of arginine-vasopressin in water-loaded rats.
Topics: Animals; Arginine Vasopressin; Diuresis; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Kidney; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1985 |
Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls.
Topics: Adult; Arginine Vasopressin; Female; Haloperidol; Humans; Male; Oxytocin; Psychiatric Status Rating Scales; Radioimmunoassay; Schizophrenia, Paranoid; Schizophrenic Psychology | 1985 |
Corticotropin-releasing factors (CRF) secreted by the rat median eminence in vitro in the presence or absence of ascorbic acid: quantitative role of vasopressin and catecholamines.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Ascorbic Acid; Biological Assay; Catecholamines; Corticotropin-Releasing Hormone; Electric Stimulation; Haloperidol; Hypothalamo-Hypophyseal System; In Vitro Techniques; Male; Median Eminence; Phentolamine; Pituitary Gland; Propranolol; Rats | 1981 |
Role of dopamine in the angiotensin II-induced vasopressin release in the conscious dehydrated dog.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Dehydration; Dogs; Female; Haloperidol; Male; Renin | 1982 |
Comparison of in vivo and in vitro corticotropin-releasing hormone-stimulated release of proopiomelanocortin-derived peptides in cats.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Bromocriptine; Cats; Cells, Cultured; Corticotropin-Releasing Hormone; Dexamethasone; Female; Haloperidol; Hydrocortisone; Injections, Intravenous; Male; Melanocyte-Stimulating Hormones; Pituitary Gland; Pro-Opiomelanocortin; Radioimmunoassay; Sheep | 1994 |
Possible contribution of dopaminergic receptors in the anteroventral third ventricular region to hyperosmolality-induced vasopressin secretion in conscious rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cerebral Ventricles; Chlorides; Dopamine; Dopamine Antagonists; Haloperidol; Injections, Intraventricular; Male; Osmolar Concentration; Pituitary Gland, Posterior; Rats; Rats, Wistar; Receptors, Dopamine; Saline Solution, Hypertonic; Sodium; Vasopressins | 1996 |
The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Arginine Vasopressin; Clozapine; Deamino Arginine Vasopressin; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Habituation, Psychophysiologic; Haloperidol; Neural Inhibition; Neurotensin; Rats; Rats, Brattleboro; Rats, Long-Evans; Rats, Mutant Strains; Reflex, Startle; Risperidone; Schizophrenia; Statistics, Nonparametric | 2007 |